Year |
Citation |
Score |
2022 |
Nataraj NB, Noronha A, Lee JS, Ghosh S, Mohan Raju HR, Sekar A, Zuckerman B, Lindzen M, Tarcitano E, Srivastava S, Selitrennik M, Livneh I, Drago-Garcia D, Rueda O, Caldas C, et al. Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors. Cell Reports. 38: 110418. PMID 35196484 DOI: 10.1016/j.celrep.2022.110418 |
0.673 |
|
2021 |
Barnabas GD, Sang Lee J, Shami T, Harel M, Beck L, Selitrennik M, Jerby-Arnon L, Erez N, Ruppin E, Geiger T. Serine biosynthesis is a metabolic vulnerability in IDH2-driven breast cancer progression. Cancer Research. PMID 33500247 DOI: 10.1158/0008-5472.CAN-19-3020 |
0.354 |
|
2020 |
Verma N, Müller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S. Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis. Cancer Research. 80: 362. PMID 31941679 DOI: 10.1158/0008-5472.CAN-19-3573 |
0.673 |
|
2019 |
Keinan O, Kedan A, Gavert N, Selitrennik M, Kim S, Karn T, Becker S, Lev S. Correction: The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis (doi:10.1242/jcs.155721). Journal of Cell Science. 132. PMID 30846603 DOI: 10.1242/Jcs.227868 |
0.682 |
|
2016 |
Verma N, Müller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S. Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4-NDRG1 axis. Cancer Research. PMID 27793840 DOI: 10.1158/0008-5472.Can-16-1797 |
0.705 |
|
2016 |
Selitrennik M, Lev S. The role of phosphatidylinositol-transfer proteins at membrane contact sites. Biochemical Society Transactions. 44: 419-24. PMID 27068949 DOI: 10.1042/BST20150182 |
0.596 |
|
2015 |
Selitrennik M, Lev S. PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop. Oncotarget. 6: 22214-26. PMID 26084289 DOI: 10.18632/oncotarget.4257 |
0.682 |
|
2015 |
Verma N, Keinan O, Selitrennik M, Karn T, Filipits M, Lev S. PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition. Nature Communications. 6: 6064. PMID 25648557 DOI: 10.1038/Ncomms7064 |
0.765 |
|
2014 |
Keinan O, Kedan A, Gavert N, Selitrennik M, Kim S, Karn T, Becker S, Lev S. The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis. Journal of Cell Science. 127: 4740-9. PMID 25179602 DOI: 10.1242/Jcs.155721 |
0.704 |
|
2013 |
Kim S, Kedan A, Marom M, Gavert N, Keinan O, Selitrennik M, Laufman O, Lev S. The phosphatidylinositol-transfer protein Nir2 binds phosphatidic acid and positively regulates phosphoinositide signalling. Embo Reports. 14: 891-9. PMID 23897088 DOI: 10.1038/Embor.2013.113 |
0.633 |
|
Show low-probability matches. |